Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
3
100%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
3(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(2)

Detailed Status

Withdrawn2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 13 (100.0%)

Trials by Status

completed133%
withdrawn267%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_1

An Imaging Study to Investigate the Distribution of GW842166X in the Brain.

NCT00511524
withdrawnphase_1

Dose Response and Efficacy of GW842166 in Pain

NCT00554762
withdrawnphase_1

Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects.

NCT00536497

Clinical Trials (3)

Showing 3 of 3 trials
NCT00511524Phase 1

An Imaging Study to Investigate the Distribution of GW842166X in the Brain.

Completed
NCT00554762Phase 1

Dose Response and Efficacy of GW842166 in Pain

Withdrawn
NCT00536497Phase 1

Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects.

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3